Doctors Note Logo

Published on: 9/13/2026

Can long-term omeprazole cause kidney disease or stomach cancer?

Long-term omeprazole use has been associated in observational research with a modestly increased risk of chronic kidney disease, acute interstitial nephritis, and gastric cancer, but these studies show correlation rather than proven cause. For most people the absolute risk remains low, and it depends heavily on dose, duration, age, H. pylori status, and existing kidney or stomach conditions, all of which are detailed below. Symptoms that deserve prompt attention include decreased urination, swelling in the legs, unexplained weight loss, difficulty swallowing, persistent vomiting, or black stools. There are several important details to weigh before continuing or stopping acid-reducing therapy, so read the complete answer below rather than the summary alone.

If you are unsure whether your symptoms point to a medication side effect or something else, a free, instant, online symptom check can help you clarify what may be happening and decide on the right next step.

Last reviewed for medical accuracy: 09/12/2026

answer background

Explanation

Can Long-Term Omeprazole Cause Kidney Disease or Stomach Cancer?

Omeprazole is a proton pump inhibitor (PPI) commonly prescribed to treat acid reflux, heartburn, peptic ulcers and other conditions involving excess stomach acid. While effective, patients and healthcare providers should be aware of potential omeprazole side effects—especially with long-term use. This article reviews current, credible evidence on whether chronic omeprazole therapy can contribute to kidney disease or stomach cancer, outlines other possible risks, and offers practical guidance.

What Is Omeprazole and Why Is It Used?

Omeprazole reduces stomach acid by blocking the proton pumps in the stomach lining. Typical uses include:

  • Gastroesophageal reflux disease (GERD)
  • Peptic ulcer disease
  • Zollinger-Ellison syndrome
  • Prevention of nonsteroidal anti-inflammatory drug (NSAID)–induced ulcers

Most patients tolerate omeprazole well when taken at the prescribed dose and duration. However, prolonged suppression of stomach acid has raised questions about safety over months or years.

Long-Term Omeprazole and Kidney Disease

Acute Interstitial Nephritis (AIN)

  • Several case reports and observational studies have linked PPIs—including omeprazole—to acute interstitial nephritis, an inflammatory condition of the kidney’s filtering units.
  • AIN can develop within days to months of starting therapy.
  • Symptoms may include decreased urine output, fatigue, nausea, and swelling.

Chronic Kidney Disease (CKD)

  • A large cohort study in the Journal of the American Society of Nephrology (2016) found that PPI users had a 20%–50% higher risk of CKD compared to non-users.
  • Proposed mechanisms:
    • Repeated episodes of AIN leading to permanent scarring
    • Altered gut microbiome increasing systemic inflammation
    • Electrolyte imbalances (e.g., low magnesium) affecting kidney function

Who Is at Highest Risk?

  • Older adults
  • People with pre-existing kidney impairment
  • Patients on multiple medications that stress the kidneys (e.g., NSAIDs, certain antibiotics)

Practical Tips to Reduce Kidney Risk

  • Use the lowest effective dose for the shortest possible duration.
  • Monitor kidney function with blood tests (serum creatinine, estimated glomerular filtration rate) if you’re on omeprazole for longer than 3 months.
  • Stay well hydrated and avoid other nephrotoxic agents when possible.
  • Report any signs of kidney problems to your doctor promptly.

Long-Term Omeprazole and Stomach Cancer

The Concern

Suppressing acid long-term can lead to hypergastrinemia (elevated gastrin levels). Gastrin stimulates growth of stomach lining cells, raising theoretical cancer risk.

What the Evidence Shows

  • Several large observational studies and meta-analyses have examined PPI use and gastric cancer risk. Most suggest a small increase in risk, but the absolute risk remains low.
  • Confounding factors:
    • Helicobacter pylori infection
    • Pre-existing atrophic gastritis
    • Smoking and high-salt diets
  • A 2018 BMJ review concluded that once H. pylori is eradicated, the cancer risk from PPIs is minimal.

Key Takeaways

  • If you have H. pylori infection, testing and eradication before starting long-term omeprazole is important.
  • Discuss with your doctor whether periodic endoscopic surveillance is warranted, especially if you have risk factors for gastric cancer.
  • For most patients without significant risk factors, the benefit of ulcer or reflux control outweighs the small potential cancer risk.

Other Notable Long-Term Omeprazole Side Effects

While kidney disease and stomach cancer are often discussed, other omeprazole side effects merit attention:

  • Nutrient malabsorption
    • Vitamin B12 deficiency (due to reduced acid needed for B12 release from food)
    • Calcium and magnesium depletion, potentially increasing osteoporosis and fracture risk
  • Increased risk of enteric infections
    • Lower acid levels can allow easier survival of pathogens like Clostridioides difficile
  • Gut microbiome alterations
    • Changes in bacterial balance may affect digestion and immune health
  • Rebound acid hypersecretion
    • Stopping omeprazole suddenly can worsen heartburn temporarily

Balancing Benefits and Risks

For many patients, omeprazole provides important relief from painful or dangerous acid-related conditions. To use it safely:

  • Reassess the need for continued therapy every 6–12 months.
  • Consider “step-down” strategies:
    • Switching to H2 blockers (e.g., ranitidine or famotidine)
    • Using antacids as needed
    • Implementing lifestyle changes (weight management, dietary modifications, head-of-bed elevation)
  • Never stop or change dose without consulting your healthcare provider.

When to Seek Medical Advice

If you experience any of the following, speak with your doctor promptly:

  • Signs of kidney problems: decreased urination, swelling, unexplained fatigue
  • Persistent or severe abdominal pain
  • Vomiting blood or black, tarry stools
  • Sudden, severe heartburn that does not improve with medication

You can also do a free, online symptom check using the doctor approved Ubie Symptom Checker to get personalized guidance.

Conclusion

Long-term omeprazole use carries some risks, including potential kidney disease and a very small increase in stomach cancer risk under certain conditions. However, for most patients with moderate to severe acid-related disorders, the benefits outweigh these risks when therapy is monitored appropriately. Always:

  • Use the lowest effective dose for the shortest duration needed
  • Monitor kidney function and nutrient levels periodically
  • Discuss risk factors for gastric cancer with your doctor
  • Explore alternative or adjunctive treatments when appropriate

If you have concerns about omeprazole side effects or any serious symptoms, please speak to a doctor without delay.

(References)

  • * Langman MJ. Omeprazole. BMJ. 1991 Aug 31;303(6801):481-2. doi: 10.1136/bmj.303.6801.481. PMID: 1680515; PMCID: PMC1670828.

  • * Omeprazole. BMJ. 1991 Nov 9;303(6811):1200-1. PMID: 1747626; PMCID: PMC1671480.

  • * Omeprazole. Lancet. 1987 Dec 19;2(8573):1467. PMID: 2892029.

  • * Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L, Zhang Y, Guo Y, Zhou T, Li JY, Shen L, Liu WD, Han ZX, Blot WJ, Gail MH, Pan KF, You WC. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 2019 Sep 11;366:l5016. doi: 10.1136/bmj.l5016. Epub 2019 Sep 11. PMID: 31511230; PMCID: PMC6737461.

  • * Fontecha-Barriuso M, Martín-Sanchez D, Martinez-Moreno JM, Cardenas-Villacres D, Carrasco S, Sanchez-Niño MD, Ruiz-Ortega M, Ortiz A, Sanz AB. Molecular pathways driving omeprazole nephrotoxicity. Redox Biol. 2020 May;32:101464. doi: 10.1016/j.redox.2020.101464. Epub 2020 Feb 12. PMID: 32092686; PMCID: PMC7038587.

  • * Su J, Chen L, Song N, Li X, Huang J, Duan P. Auricular Point-Pressing With Bean Plus Esomeprazole Magnesium in Relieving Gastrointestinal Dysfunction. Altern Ther Health Med. 2022 Nov;28(8):16-22. PMID: 35839117.

  • * Crafa P, Franceschi M, Rodriguez-Castro KI, Franzoni L, Russo M, Brandimarte G, Tursi A, Rugge M, Di Mario F. PPIs and gastric cancer: any causal relationship? Acta Biomed. 2023 Jun 14;94(3):e2023096. doi: 10.23750/abm.v94i3.14105. Epub 2023 Jun 14. PMID: 37326271; PMCID: PMC10308480.

  • * Kim BW, Park JJ, Moon HS, Lee WS, Shim KN, Baik GH, Lim YJ, Lee HL, Youn YH, Park JC, Sung IK, Chung H, Moon JS, Kim GH, Hong SJ, Choi HS. The Effect of Tegoprazan on the Treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled Study. Gut Liver. 2024 Mar 15;18(2):257-264. doi: 10.5009/gnl230242. Epub 2024 Feb 22. PMID: 38384180; PMCID: PMC10938149.

  • * Pan KF, Li WQ, Zhang L, Liu WD, Ma JL, Zhang Y, Ulm K, Wang JX, Zhang L, Bajbouj M, Zhang LF, Li M, Vieth M, Quante M, Wang LH, Suchanek S, Mejías-Luque R, Xu HM, Fan XH, Han X, Liu ZC, Zhou T, Guan WX, Schmid RM, Gerhard M, Classen M, You WC. Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial. Nat Med. 2024 Nov;30(11):3250-3260. doi: 10.1038/s41591-024-03153-w. Epub 2024 Jul 30. PMID: 39079993.

  • * Zhang J, An J. Updating understanding of real-world adverse events associated with omeprazole. PLoS One. 2025;20(8):e0330509. doi: 10.1371/journal.pone.0330509. Epub 2025 Aug 20. PMID: 40834017; PMCID: PMC12367145.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.